期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
主动脉缩窄合并症及主动脉缩窄外科术后并发症的介入治疗策略 被引量:6
1
作者 吴文辉 黄连军 +4 位作者 薛玉国 蒲俊舟 黄小勇 濮欣 刘光锐 《中国介入心脏病学杂志》 2019年第6期315-321,共7页
目的探讨主动脉缩窄(CoA)合并症及CoA外科术后并发症介入治疗的可行性。方法2009年6月至2016年12月北京安贞医院6例Co A合并急性主动脉综合征或CoA外科术后并发假性动脉瘤患者接受介入治疗。男5例,女1例;年龄44~56(50.3±5.01)岁。... 目的探讨主动脉缩窄(CoA)合并症及CoA外科术后并发症介入治疗的可行性。方法2009年6月至2016年12月北京安贞医院6例Co A合并急性主动脉综合征或CoA外科术后并发假性动脉瘤患者接受介入治疗。男5例,女1例;年龄44~56(50.3±5.01)岁。患者术前均经主动脉CT血管造影(CTA)确诊。根据患者主动脉解剖及病理生理特点制定介入治疗方案,4例患者(2例主动脉缩窄合并B型主动脉夹层,1例主动脉缩窄合并穿通性溃疡,1例外科术后缩窄复发合并假性动脉瘤),行胸主动脉腔内修复术(TEVAR)治疗;1例患者Co A外科术后吻合处假性动脉瘤形成采用TEVAR,并对外科姑息的缩窄进行栓塞;1例CoA合并B型主动脉夹层,外科先行升主动脉至降主动脉人工血管转流,再对缩窄处进行封堵。结果介入治疗技术成功率100%。围术期无并发症发生。随访10~60个月,无主动脉相关死亡和再次介入或外科手术干预治疗。结论解剖条件合适的Co A合并症或Co A外科术后并发假性动脉瘤患者可首先尝试TEVAR治疗。解剖条件不合适的Co A合并B型主动脉夹层患者可行复合手术。此类患者应根据解剖及病理生理特点个体化选择手术方式及介入器材。 展开更多
关键词 主动脉缩窄 合并症 心血管外科手术 介入治疗
下载PDF
非小细胞肺癌患者化疗期间肺部感染分离的产超广谱β-内酰胺酶病原菌耐药基因检测 被引量:17
2
作者 叶晓明 朱婉红 +2 位作者 黄连军 程正文 杨平满 《中华医院感染学杂志》 CAS CSCD 北大核心 2019年第2期166-170,共5页
目的 分析非小细胞肺癌(NSCLC)患者化疗期间肺部感染分离的产超广谱β-内酰胺酶(ESBLs)病原菌耐药性及基因表型,以指导临床治疗。方法 统计2016年6月-2017年10月收治的420例NSCLC患者在化疗期间肺部感染发生情况,采集感染患者临床标本... 目的 分析非小细胞肺癌(NSCLC)患者化疗期间肺部感染分离的产超广谱β-内酰胺酶(ESBLs)病原菌耐药性及基因表型,以指导临床治疗。方法 统计2016年6月-2017年10月收治的420例NSCLC患者在化疗期间肺部感染发生情况,采集感染患者临床标本进行细菌培养及药敏试验,采用PCR技术检测产ESBLs病原菌的耐药基因。结果 420例NSCLC患者在化疗期间,97例患者发生肺部感染,感染率为23.10%;共检出革兰阴性菌87株,产ESBLs细菌35株,占40.23%,其中肺炎克雷伯菌占37.14%、大肠埃希菌和铜绿假单胞菌各占28.57%;35株产ESBLs细菌对青霉素及头孢菌素高度耐药,其中对氨苄西林/克拉维酸、氨苄西林、头孢唑林、头孢曲松的耐药率达100.00%,对β-内酰胺类抗菌药物/酶抑制剂复合物部分耐药,耐药率为14.29%~20.00%,对碳青霉烯类抗菌药物保持良好敏感性;TEM型菌株检出率最高,占31.43%,其次为CTX-M-9型菌株,占25.71%,同时携带两种或两种以上基因型的菌株5株,占14.29%。结论 NSCLC化疗患者肺部感染产ESBLs细菌具有多药耐药的基因表型特征,临床应加强对肺部感染产ESBLs细菌的监测,并根据药敏结果指导用药。 展开更多
关键词 肺部感染 非小细胞肺癌 超广谱Β-内酰胺酶 耐药基因
原文传递
Treatment of aortic pseudoaneurysm with interventional procedure 被引量:5
3
作者 huang lian-jun YU Fei-cheng +5 位作者 SUN Li-zhong TIAN Liang-xin CHU Jun-min Lu Jian-hua JIN Jing-lin JIANG Shi-liang 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第7期612-616,共5页
The prognosis of aortic pseudoaneurysm is bad because it usually threats to life by hemorrhea.Conventional surgical repair is usually associated with high morbidity and mortality, especially in patients with poor cond... The prognosis of aortic pseudoaneurysm is bad because it usually threats to life by hemorrhea.Conventional surgical repair is usually associated with high morbidity and mortality, especially in patients with poor condition. Recent reports have shown promising results with endovascular treatment as a less invasive alternative to surgery. Fourteen patients with aortic pseudoaneurysms were treated by interventional procedure in our hospital. 展开更多
关键词 aortic pseudoaneurysm endovascular stent-graft occlusion device interventional therapy
原文传递
Use of covered Cheatham-Platinum stent as the primary modality in the treatment for native coarctation of the aorta 被引量:4
4
作者 CHANG Zong-ping JIANG Shi-liang +11 位作者 XU Zhong-ying ZHANG Ge-jun huang lian-jun ZHAO Shi-hua LING Jian ZHENG Hong JIN Jing-lin WU Wen-hui HU Hai-bo LI Shi-guo YU Ji-hong YAN Chao-wu 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第6期1005-1009,共5页
Background Bare stent implantation in the treatment for native and recurrent coarctation of the aorta (CoA) has become established as an alternative to surgery and balloon angioplasty. However, this modality still e... Background Bare stent implantation in the treatment for native and recurrent coarctation of the aorta (CoA) has become established as an alternative to surgery and balloon angioplasty. However, this modality still encounters significant complications during the procedure and/or follow-up. The covered Cheatham-Platinum (CP) stent commonly used to be chosen as a rescue treatment in these patients. The purpose of this study was to evaluate the use of covered CP stent as the primary modality in the treatment for native CoA. Methods Twenty-five covered CP stents and 2 bare CP stents were implanted in 25 patients with native CoA. All patients after the intervention were invited for follow-up examinations. Results The peak systolic gradient across the lesion decreased significantly from a median value of 67.5 mmHg (quartile range, 19.3 mmHg) to 2 mmHg (quartile range, 4.0 mmHg) (P 〈0.0001). Stenotic segment diameter increased from a median value of 5.0 mm (quartile range, 1.5 mm) to 17.9 mm (quartile range, 2.5 mm) (P 〈0.0001). The median ratio of diameter of the coarctation postprocedure to preprocedure was 4.2 (quartile range, 1.6). All of the CP stents were placed in the suitable position without any acute complications. During a follow-up period of up to 72 months, no complications were encountered. Most of the patients (21/25) were normotensive, apart from four patients requiring antihypertensive medication during the follow-up. Conclusion The implantation of covered CP stent as the primary modality is safe and effective in the treatment for native CoA in adolescents and adults. 展开更多
关键词 aortic coarctation STENT CATHETERIZATION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部